AZD6738
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for AZD6738, covering 2014-06-19 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) [Phase 1]